MARATTO

article · Journal of International Medical Research

Epidemiology of asymptomatic peptic ulcer disease diagnosed during screening endoscopy in patients with cirrhosis

Abstract

Objective Asymptomatic peptic ulcer disease (PUD) is frequently overlooked in patients with cirrhosis, who are at increased risk for gastrointestinal complications that can lead to increased morbidity and mortality. We aimed to determine the prevalence and associated factors of asymptomatic PUD identified during screening endoscopy in patients with cirrhosis. Methods We conducted a retrospective cross-sectional study among patients with cirrhosis at St. Paul’s Hospital Millennium Medical College in Ethiopia. Data were collected using a structured questionnaire from patients’ medical charts. A logistic regression model was used to identify predictors of peptic ulcer. Results This study included 296 patients, revealing that 19.6% had PUD (95% confidence interval: 13.5–26.4). Significant associations were found between peptic ulcer and Helicobacter pylori infection, moderate and heavy alcohol consumption, and Child–Pugh class C cirrhosis. Conclusion We found that patients with liver cirrhosis are more likely to have asymptomatic peptic ulcers. Asymptomatic PUD was linked to H. pylori infection, greater alcohol consumption, and Child–Pugh class C liver disease, highlighting the need for targeted prevention and management strategies to reduce morbidity in patients with cirrhosis, such as eradication therapy for H. pylori and counseling on alcohol use.

Research topics

  • Helicobacter pylori-related gastroenterology studies
  • Liver Disease and Transplantation
  • Gastrointestinal motility and disorders

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/03000605241305258

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.